Advanced Wound Dressing Market Scope And Analysis

Report Code : TIPRE00027861
Category : Medical Device

No. of Pages : 150

Buy Now

Advanced Wound Care Dressing Market Scope, Analysis, and Trends by 2030

Buy Now

Advanced Wound Care Dressing Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 4,333.25 Million
Market Size by 2030	US$ 6,629.49 Million
Global CAGR (2022 - 2030)	5.46%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Type Foam Dressing Alginate Dressing Hydrocolloid Dressing Film Dressing Hydrogel Dressing Collagen Dressing By Application Heavy Exudated Wounds Burns and Scalds Ulcers/Bedsores/Cavity Wounds Post-Operative Wounds and Injuries By End User Hospitals and Clinics Specialty Centers Homecare Settings
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	TRIAGE MEDITECH PVT LTD Convatec Group PLC MedSupply Inc Smith and Nephew HARTMANN USA Inc Medtronic Medical Monks 3M M lnlycke Health Care AB

Regional Analysis

The North America advanced wound care dressing market is segmented into the US, Canada, and Mexico. The market growth can be attributed to the increasing number of acquisitions by top market players operating in the region. The advanced wound care dressing market in the US is expected to witness significant growth due to rapid technological advancements, and rising medical expenditure in healthcare.

The report profiles leading players operating in the global advanced wound care dressing market. These include TRIAGE MEDITECH Pvt. Ltd; Convatec Group PLC; MedSupply Inc.; Smith and Nephew; HARTMANN USA, Inc.; Medtronic; Medical Monks; 3M; Mölnlycke Health Care AB; Coloplast Corp; and MEDCU.

In August 2022, 3M Health Care's Medical Solutions Division introduced a new and advanced version of 3M Veraflo Therapy. The updated version comes with a new 3M Veraflo Cleanse Choice Complete Dressing Kit and a software upgrade for the 3M V.A.C. Ulta Therapy Unit, which is available to customers at no additional cost. These new offerings help simplify the care delivery processes for clinicians using Veraflo Therapy, a negative pressure wound therapy with instillation, and make dressing changes faster, easier, and less painful for their patients compared to previous Veraflo Therapy dressings.
In January 2022, Convatec Group Plc entered into a definitive agreement to acquire Triad Life Sciences Inc., a medical device company based in the US. Triad engages in the development of biologically-derived innovative products to address unmet clinical needs for managing surgical wounds, chronic wounds, and burns. The transaction was closed in Q1 2022, subject to regulatory approvals and other customary conditions.